Objective: To determine the specific morphology of the pituitary gland in children with severe isolated GH deficiency due to GH-1 gene mutations (IGHD type II). Design: The pituitary gland morphology in magnetic resonance imaging (MRI) of children with IGHD type II was analyzed and compared with the findings in a group of children with comparably severe IGHD of unknown origin. In addition, the birth histories of both groups were studied. Subjects: Thirteen children with IGHD type II were diagnosed in seven European children's hospitals and they carried a corresponding GH-1 gene mutation. For comparison, we selected from a group of 66 MRI-studied GH-insufficient subjects diagnosed in our clinic, all children with severe IGHD (all GH peaks , 4 mg/l) who had no GH-1 gene mutation, no first-grade relative with IGHD and no septo-optic dysplasia. Methods: Sagittal and coronal images of the brain were analyzed for the presence of any malformation of the pituitary gland and the intracranium. The height of each adenohypophysis was measured in a strict midline sagittal image for quantification of the gland's size. In addition, patients' files were reviewed for birth trauma or breech delivery. Results: Normal MRI morphology of the pituitary gland was observed in all patients of the familial IGHD type II group ðP , 0:003Þ in which, however, five of thirteen patients (38%) exhibited a mild hypoplasia of their gland (mean sagittal adenohypophysial height 21:0^0:03 SD score (SDS)). In contrast, the pituitary gland in the idiopathic group showed a definitive malformation with hypoplasia of pituitary stalk and adenohypophysis in all cases, while ectopia of the neurohypophysis was present in nine of the ten cases. The adenohypophysis was significantly smaller in the idiopathic group (mean sagittal adenohypophysial height 23:2^0:3 SDS) ðP , 0:0001Þ: All thirteen birth histories in the familial group (IGHD type II) were unremarkable while, in the idiopathic group, three of eight available birth histories recorded a breech delivery or traumatic birth (37.5%) ðP , 0:05Þ: Conclusions: This study shows for the first time that MRI pituitary morphology may correlate with the etiology of severe IGHD: normal morphology suggests the presence of GH-1 gene mutations, while severe hypoplasia with malformation have other causes which might include so far unknown genetic defects as well as traumatic insults.
Introduction
Studies on magnetic resonance imaging (MRI) morphology of the pituitary gland in individuals with isolated growth hormone deficiency (IGHD) have shown that anatomic abnormalities are frequent (1, 2) . A malformation pattern with hypoplastic adenohypophysis, hypoplastic, truncated or absent pituitary stalk and ectopic neurohypophysis has been described and correlated with the results of growth hormone (GH) stimulation tests (3, 4) . However, two major systematic problems have not been sufficiently solved: first, when testing the impact of MRI on the diagnosis and/or cause of IGHD in childhood, a safe standard for the clinical verification of IGHD is urgently needed. This, however, has proved to be difficult (5) . Secondly, although much effort has been put into studies focusing on pituitary gland development, pathogenetic insights into the etiology of the described pituitary gland malformations are still missing (6) .
In depth molecular analysis of the genes coding for the pituitary hormones including the GH-1-gene and the discovery of several transcription factors involved in the organogenesis of the pituitary gland promise a better understanding of hereditary malfunctions and malformations of the pituitary gland (6, 7) . Importantly, these entities must be separated from conditions of secondary damage to the pituitary gland which might be caused by perinatal or postnatal adverse events (8) .
The aim of this study was to define the specific pituitary gland morphology assessed by MRI of patients with familial IGHD type II due to GH-1 gene mutations (9) and to compare these findings with the gland morphology found in patients with idiopathic IGHD who exhibited a similar biochemical and clinical severity. In addition, perinatal history was studied in both groups in order to re-examine the perinatal trauma hypothesis as a cause for severe IGHD (8) .
Subjects and methods

Subjects
The thirteen children with familial IGHD type II had been diagnosed in seven different European children's hospitals during the last 18 years. The genetic analysis of the cases was performed in two research centres, Tübingen, Germany (G B) and Bern, Switzerland (P E M) during the last 8 years, as previously reported (7, 10) . All thirteen children carried a heterozygous mutation of the GH-1 gene which accounts for the dominantly transmitted form of familial GHD (IGHD type II). The molecular and clinical characteristics of the patients are shown in Table 1 (with SD scores (SDS) according to Prader et al., 11) . Patients 3a and 3b as well as patients 4a and 4b were siblings, while patients 9a and 9b were first-grade cousins. Patients 10a and 10b were second-grade cousins. With the exception of patient 1 who had a de novo mutation, all children had one affected parent. Arginine-and insulin-stimulated GH secretion of these children did not increase above a serum level of 4 mg GH/l, with one exception (patient 3a: 5.0 mg GH/l following insulin stimulation). In addition, perinatal histories were reviewed from the available records for breech delivery, Caesarean section, precipitate delivery and neonatal hypoxia. MRI morphology was obtained at a median age of 13 years (range 7 -18 years) in nine cases during the diagnostic work-up, and in four cases who had been diagnosed in the pre-MRI era later in connection with this study after obtaining informed consent from parents and patients.
For comparison, we selected all children with analogous severe IGHD (defined by all GH peaks , 4 mg/l after arginine and insulin stimulation) from a group of 66 MRI-studied children who had been examined by MRI in our endocrine clinic because of GH insufficiency over 4 consecutive years (3) . The clinical characteristics and the data from the birth records of this second group which contained ten children are shown in Table 2 . The other 56 MRI-studied children were excluded from this study because of multiple pituitary hormone deficiency ðn ¼ 13Þ; non-severe GHD with at least one GH peak level . 4 mg/l ðn ¼ 37Þ; amaurosis ðn ¼ 2Þ; proven GH-1 gene mutation (n ¼ 1; incorporated in the other study group), presence of a first-grade relative with IGHD ðn ¼ 2Þ; or absence of sufficient pituitary imaging ðn ¼ 1Þ: It must be emphasized that the selection of the ten children was exclusively based on clinical, endocrine and molecular data, not on the MRI results which were present in all cases, but explored thereafter. Table 1 The molecular and clinical characteristics and birth histories of the 13 patients with IGHD type II.
Patient
Sex Nationality
Age at diagnosis (years)
Height at diagnosis (SDS)
Growth velocity before/with rhGH (SDS)
GH-1 gene mutation GH peak (Arg;Ins) (mg/l) Birth 
Methods
MRI examinations were carried out in different radiology centers. Sagittal and coronal T1 images were taken using various repetition times from 320 to 472 ms and an echo time of 20 or 25 ms through the sella region with contiguous slices of between 2.5 and 4 mm thickness. In addition, axial T1 and T2 images of the whole brain were carried out. Images were acquired on a 256 £ 256 or 512 £ 512 matrix. Gadolinium injection was performed in all patients. The images were co-analyzed according to the same protocol by one experienced neuroradiologist and one paediatric endocrinologist (G B in Tü bingen, Germany, P E M in Bern, Switzerland). Adenohypopysial height was determined in a strict midline-positioned sagittal scan which displayed the anterior lobe, the posterior lobe, the stalk of the pituitary gland and the Sylvius aqueduct simultaneously. Maximal height of the pituitary gland was measured perpendicular to the sella turcica floor, after magnification through an overhead projector using the scaling provided on the films (accuracy of measurement: 0.1 mm). Since the height of the pituitary gland increases with age, the measurements had to be compared with the normative data reported by Argyropoulou et al. (12) . A pituitary gland with a height 2 2.0 SDS was defined as hypoplastic. The stalk was taken as hypoplastic if there was a significant reduction at any level in its diameter or irregularity along its length. Ectopia of the neurohypophysis was diagnosed on the basis of lack of visualization of the high signal on T1 image in the sella turcica, and the presence of this signal in the infundibular recess of the third ventricle. Finally, the MRI scans were assessed for midline defects such as agenesis of corpus callosum, optic nerve hypoplasia, Chiari I malformation and any other abnormality of the brain.
Statistical analysis
For comparison of the pituitary malformation frequencies of both groups, we used Fischer's exact test and computed the two-tailed P values. Sagittal hypophysial height, a continuous variable, was investigated after correction for age to SDS by a 95% confidence interval for the difference of means between both study groups (1, 12) . In addition, a two sample t-test was performed to calculate the P value. The increase of pituitary height with age in both groups was computed in an analysis of covariance.
Results
The MRI morphology of the pituitary gland analyzed by qualitative assessment according to a detailed protocol was significantly different in the two study groups ðP , 0:003Þ: Gross abnormalities which comprise hypoplasia of the adenohypophysis, hypoplastic or absent stalk and ectopia of the neurohypophysis were absent in familial IGHD type II, but present in all patients with idiopathic IGHD except one who did not present any ectopia (Table 3) . No additional intracranial malformations were found in any individual of both groups.
The measures of the adenohypophysial height were significantly smaller in the idiopathic cases ðP , 0:0001Þ (Fig. 1) . Mean sagittal height was 21:0^0:3 SDS in the familial IGHD type II group, but 23:20 :3 SDS in the idiopathic IGHD group. The 95% confidence interval for the difference of means was 1.3 -3.0 SDS. In addition, the physiological increase of the pituitary height with age was present in the IGHD type II group, but not in the idiopathic group (slope of the linear fit þ 0.17 versus 2 0.01); this observation, however, did not reach significance ðP , 0:066Þ:
Analysis of the eight available birth records of the children affected with idiopathic IGHD revealed two Table 2 The clinical characteristics and birth histories of the patients with idiopathic IGHD.
Patient
Height at diagnosis (SDS)
Growth velocity before/with rhGH (SDS) 
Discussion
In most of the patients with familial IGHD type II, the pituitary gland morphology was completely normal. A third of the patients had a mild hypoplasia of their adenohypophysis. Normal anatomy of the adenohypophysis was also reported from two patients with homozygous GH-1 gene deletion (IGHD type Ia) (12), while severe hypoplasia of the adenohypophysis was reported in patients with GHD due to a GH-releasing hormone receptor (GHRHR) mutation (subsumed under IGHD type Ib) (14) . Hypoplasia of the adenohypophysis is also the most frequent finding in patients with multiple pituitary hormone deficiency due to POU1F1 or PROP1 deficiency (6) . The contrasting aspects of the pituitary gland in these four monogenetic GHDs are most likely the result of the different underlying pathogenesis: a functional disturbance of the somatotrope cells (GH-1 gene defects) does not reduce the somatotrope cell count, but this happens in those disorders which primarily disturb the normal cell proliferation during pituitary embryogenesis (GHRHR, POU1F1 or PROP1 defects). Although morphological analyses of the pituitary gland applying MRI methods have often been performed Table 3 The number of patients with specific MRI findings versus the total number of patients in each group. in patients with IGHD, we, for the first time, compared the morphological data from patients with familial and idiopathic IGHD having a similar degree of GHD in terms of peak levels of pharmacologically stimulated GH. The analysis of the growth data also showed nearly identical mean height deficits before treatment and mean growth velocities during the first year of treatment in both groups. It is important to stress that the morphology of the pituitary glands differed clearly between these two groups with severe IGHD that were studied. Severe malformation of the pituitary gland with hypoplasia of the adenohypophysis and of its stalk as well as ectopia of the neurohypophysis was found in all patients with idiopathic IGHD except one who presented with a normally positioned neurohypophysis (90%). Such a high percentage of pituitary malformation in severe idiopathic IGHD was also reported previously by others who used the same strict definition of IGHD with a GH serum cut-off level at or below 4 mg/l (4, 15, 16). Studies which included the whole spectrum of GHD (GH serum cut-off level at 10 mg/l) detected the malformation trias of the pituitary gland in only 10% of the individuals having GHD (17, 18) , indicating an inverse correlation of GH cut-off level chosen and frequency of pituitary gland malformations observed in GHD individuals. The very high prevalence of pituitary malformation in severe IGHD in general (this study, 4, 15, 16) and the finding of the absence of pituitary malformation in severe familial IGHD type II presented here lead us to conclude that children with severe IGHD (cut-off level at 4 mg/l) but completely normal MRI pituitary anatomy are likely to carry a GH-1 gene mutation.
The pathogenetic basis of the malformation complex of the pituitary gland found in the idiopathic cases is still unclear. Because of its characteristic pattern, a genetic basis was postulated, but has not yet been proven (6) . The occurrence of such malformations and GHD after accidents with head trauma in childhood supports the theory that a mechanic trauma of the pituitary gland and its stalk could also be causative (19) . Accordingly, it has been speculated that similar neonatal traumas due to breech delivery could injure the pituitary gland with the residual of malformation and malfunction (8) . Interestingly, traumatic perinatal events were significantly more frequent in our idiopathic IGHD group than in the familial IGHD group. This observation, however, does not exclude an additional and/or alternative genetic basis for pituitary malformations (20) .
In conclusion, this study shows that pituitary gland morphology may indicate the etiology of severe IGHD. Importantly, normal morphology was present in familial GHD (IGHD type II) while severe malformation was typical for severe idiopathic IGHD. In addition, the occurrence of malformations correlated with a higher frequency of perinatal traumas due to precipitate or breech delivery when compared with data obtained from the patients suffering from IGHD type II. The combination of severe GHD and normal pituitary gland morphology is a characteristic feature of IGHD type II.
